I would be surprised if the trial finished prematurely based on the relatively rare incidence of such examples. I think it would be awesome and welcomed, but unlikely.
I have spent time with retts patients, and I would consider their condition worthy of fast tracked trials. But, I'm not a part of the FDA or the ethics committee. Time will tell. If they dont fast track the trial, well I turn out to be right. In the unlikely event they do end the trial early, I'll be very very happy to admit I was wrong.
retts syndrome, page-29
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.81 |
Change
0.060(0.44%) |
Mkt cap ! $1.765B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $6.963M | 507.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3724 | $13.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.84 | 2087 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |